Cooke & Bieler LP Lowers Position in Markel Group Inc. $MKL

Cooke & Bieler LP lowered its holdings in Markel Group Inc. (NYSE:MKL) by 3.3% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 32,067 shares of the insurance provider’s stock after selling 1,090 shares during the quarter. Cooke & Bieler LP owned approximately 0.25% of Markel Group worth $61,292,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of MKL. Brighton Jones LLC purchased a new stake in Markel Group during the fourth quarter worth $236,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Markel Group by 13.5% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 109 shares of the insurance provider’s stock valued at $204,000 after acquiring an additional 13 shares during the period. Goldman Sachs Group Inc. raised its position in shares of Markel Group by 9.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 34,704 shares of the insurance provider’s stock worth $64,883,000 after acquiring an additional 3,083 shares in the last quarter. Empowered Funds LLC lifted its stake in shares of Markel Group by 49.1% during the 1st quarter. Empowered Funds LLC now owns 416 shares of the insurance provider’s stock worth $778,000 after purchasing an additional 137 shares during the last quarter. Finally, Farther Finance Advisors LLC lifted its stake in shares of Markel Group by 17.6% during the 2nd quarter. Farther Finance Advisors LLC now owns 154 shares of the insurance provider’s stock worth $308,000 after purchasing an additional 23 shares during the last quarter. 77.12% of the stock is currently owned by institutional investors.

Markel Group Stock Down 1.0%

NYSE:MKL opened at $2,025.71 on Monday. The company has a current ratio of 0.60, a quick ratio of 0.60 and a debt-to-equity ratio of 0.24. Markel Group Inc. has a twelve month low of $1,621.89 and a twelve month high of $2,207.59. The company has a market cap of $25.54 billion, a PE ratio of 12.68 and a beta of 0.80. The company’s 50 day moving average is $2,105.42 and its two-hundred day moving average is $2,007.68.

Markel Group (NYSE:MKL) last posted its quarterly earnings data on Wednesday, October 29th. The insurance provider reported $30.90 EPS for the quarter, topping the consensus estimate of $22.77 by $8.13. The business had revenue of $3.93 billion during the quarter, compared to the consensus estimate of $3.77 billion. Markel Group had a net margin of 12.99% and a return on equity of 7.76%. Analysts anticipate that Markel Group Inc. will post 96.25 EPS for the current year.

Insider Transactions at Markel Group

In other news, CEO Simon Wilson sold 75 shares of the firm’s stock in a transaction dated Tuesday, November 25th. The stock was sold at an average price of $2,072.94, for a total value of $155,470.50. Following the completion of the transaction, the chief executive officer directly owned 1,770 shares in the company, valued at $3,669,103.80. This trade represents a 4.07% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Steven A. Markel sold 1,330 shares of the company’s stock in a transaction that occurred on Thursday, December 11th. The shares were sold at an average price of $2,119.12, for a total value of $2,818,429.60. Following the completion of the sale, the director owned 60,368 shares in the company, valued at approximately $127,927,036.16. This represents a 2.16% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 1,575 shares of company stock worth $3,330,900 over the last three months. Corporate insiders own 1.66% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on MKL. Zacks Research lowered Markel Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, January 19th. Weiss Ratings restated a “buy (b+)” rating on shares of Markel Group in a report on Monday, December 29th. Finally, TD Cowen reiterated a “hold” rating on shares of Markel Group in a research note on Tuesday, October 7th. Two research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $2,025.00.

Markel Group Profile

Markel Group (NYSE: MKL) is a diversified insurance holding company best known for underwriting specialty insurance products. Founded in 1930 and headquartered in Richmond, Virginia, the company provides a wide range of commercial property and casualty coverages tailored to niche and hard-to-place risks. Its underwriting operations focus on specialty lines across multiple industries, delivering customized policy structures, program administration, and claims management services for complex exposures.

In addition to primary specialty insurance, Markel operates reinsurance and alternative risk-transfer activities and manages invested assets derived from underwriting float.